Silverman et al. [(1)][1] report that in a meta-regression analysis, the use of statin and nonstatin therapies that act via upregulation of low-density lipoprotein (LDL) receptor expression to reduce LDL cholesterol… Click to show full abstract
Silverman et al. [(1)][1] report that in a meta-regression analysis, the use of statin and nonstatin therapies that act via upregulation of low-density lipoprotein (LDL) receptor expression to reduce LDL cholesterol (LDL-C) were associated with similar relative risks of major vascular events per
               
Click one of the above tabs to view related content.